Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว$310,083 ปริมาณ
Mar 31, 2026
June 30
13%
December 31
38%
$310,083 ปริมาณ
June 30
$19,514 ปริมาณ
13%
December 31
$25,686 ปริมาณ
38%
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ตลาดเปิดเมื่อ: Feb 7, 2026, 5:04 PM ET
ปริมาณการซื้อขาย
$310,083วันสิ้นสุด
Mar 31, 2026ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by March 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
This market will resolve to "Yes" if marijuana is rescheduled down from I to any other level (or is unscheduled completely) by the Drug Enforcement Agency of the United States (https://www.dea.gov/drug-information/drug-scheduling), by June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
ปริมาณการซื้อขาย
$310,083วันสิ้นสุด
Mar 31, 2026ตลาดเปิดเมื่อ
Feb 7, 2026, 5:04 PM ETResolver
0x65070BE91...Trader consensus on Polymarket reflects uncertainty in the federal marijuana rescheduling process, with year-end resolution options like December 31 leading near 50% implied probability amid ongoing delays. President Trump's December 2025 executive order directed the Attorney General to expedite moving cannabis from Schedule I to Schedule III of the Controlled Substances Act, following HHS's prior scientific recommendation and DEA's proposed rulemaking. As of mid-April 2026, DOJ stated the process is in its final phase after incorporating DEA input and over 43,000 public comments, but DEA filings confirm administrative appeals remain pending, prompting a Trump advisor to cite internal hold-ups and Rep. Steve Cohen's March letter demanding a timeline. No firm issuance date is set, with potential for final rule soon or further procedural hurdles.
สรุปจาก AI ทดลองที่อ้างอิงข้อมูลจาก Polymarket ไม่ใช่คำแนะนำในการเทรดและไม่มีผลต่อการตัดสินตลาดนี้ · อัปเดตแล้ว
ระวังลิงก์ภายนอก
ระวังลิงก์ภายนอก
คำถามที่พบบ่อย